Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ABAXIS INC | 57,100 | reported | 31 Jul 2018 | tx 138+135,000−194,500 |
| Armata Pharmaceuticals, Inc. | 23,000 | reported | 08 Dec 2020 | tx 2+50,383 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 08 Dec 2020 | GRANT_AWARD | Armata Pharmaceuticals, Inc. | 23,000 | 0.00 USD | deriv |
| 22 May 2019 | GRANT_AWARD | Armata Pharmaceuticals, Inc. | 27,383 | 0.00 USD | deriv |
| 31 Jul 2018 | GIFT | ABAXIS INC | 300 | 0.00 USD | |
| 31 Jul 2018 | OTHER | ABAXIS INC | 57,100 | 83.00 USD | |
| 31 Jul 2018 | OTHER | ABAXIS INC | 5,500 | — | deriv |
| 01 May 2018 | EXERCISE | ABAXIS INC | 5,500 | 0.00 USD | |
| 01 May 2018 | EXERCISE | ABAXIS INC | 5,500 | 0.00 USD | deriv |
| 30 Apr 2018 | GRANT_AWARD | ABAXIS INC | 5,500 | 0.00 USD | deriv |
| 02 May 2017 | EXERCISE | ABAXIS INC | 5,500 | 0.00 USD | |
| 02 May 2017 | EXERCISE | ABAXIS INC | 5,500 | 0.00 USD | deriv |
| 01 May 2017 | GRANT_AWARD | ABAXIS INC | 5,500 | 0.00 USD | deriv |
| 01 Feb 2017 | SALE | ABAXIS INC | 1,222 | 51.35 USD | |
| 01 Feb 2017 | SALE | ABAXIS INC | 778 | 51.40 USD | |
| 01 Feb 2017 | SALE | ABAXIS INC | 100 | 51.42 USD | |
| 01 Feb 2017 | SALE | ABAXIS INC | 100 | 51.48 USD | |
| 01 Feb 2017 | SALE | ABAXIS INC | 200 | 51.50 USD | |
| 02 Feb 2017 | SALE | ABAXIS INC | 270 | 50.65 USD | |
| 02 Feb 2017 | SALE | ABAXIS INC | 130 | 50.66 USD | |
| 02 Feb 2017 | SALE | ABAXIS INC | 300 | 50.67 USD | |
| 02 Feb 2017 | SALE | ABAXIS INC | 200 | 50.68 USD | |
| 02 Feb 2017 | SALE | ABAXIS INC | 100 | 50.71 USD | |
| 02 Feb 2017 | SALE | ABAXIS INC | 300 | 50.72 USD | |
| 02 Feb 2017 | SALE | ABAXIS INC | 200 | 50.73 USD | |
| 02 Feb 2017 | SALE | ABAXIS INC | 100 | 51.15 USD | |
| 08 Jun 2016 | SALE | ABAXIS INC | 1,000 | 46.11 USD |
1 purchase reported after at least 12 months of silence — most recent on 24 Oct 2013.